Latest News and Press Releases

Borregaard’s operating revenues were NOK 1,605 million (NOK 1,770 million)2 in the 4th quarter of 2023. EBITDA1 was NOK 327 million (NOK 364 million). The result in BioSolutions improved while...

31 January 2024: Borregaard ASA («Borregaard», OSE ticker: BRG) At a meeting on 30 January 2024, the Board of Directors of Borregaard ASA decided to propose to the Annual General Meeting an ordinary...

24 January 2024: Borregaard ASA (”Borregaard”, OSE ticker: BRG) Presentation of Q4 2023 results Borregaard will report fourth quarter 2023 results on Wednesday 31 January 2024 at 07:00 CET. A stock...

Borregaard will co-invest with the European Innovation Council Fund and several other public and private investors in a direct offering of new shares in the Danish bioscience company Kaffe Bueno ApS....

During the 4th quarter of 2023, operational issues have affected production at the Sarpsborg site, reducing the result mainly in BioMaterials. Following the annual maintenance stop in October, the...

04.12.2023: Borregaard ASA (”Borregaard”, OSE ticker: BRG) Reference is made to the stock exchange notice of 17 November 2023 where Borregaard announced the intent to repurchase up to 200,000 of its...

28.11.2023: Borregaard ASA (”Borregaard”, OSE ticker: BRG) Reference is made to the stock exchange notice of 17 November 2023 where Borregaard announced the intent to repurchase up to 200,000 of...

17 November 2023: Borregaard ASA ("Borregaard", OSE ticker: BRG) Borregaard intends to repurchase up to 200,000 shares of its outstanding common stock. The shares will be used for employee incentive...

Today, Sveinung Heggen, General Counsel, exercised 15,000 stock options at a strike price of NOK 67.05 per share and in separate transactions, purchased and sold the same number of shares. The shares...

Borregaard’s operating revenues were NOK 1,714 million (NOK 1,752 million)2 in the 3rd quarter of 2023. EBITDA1 increased to NOK 482 million (NOK 434 million). BioMaterials and Fine Chemicals had...